These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2297924)

  • 1. Digoxin-like immunoreactive substances in kidney- and liver-transplant patients.
    Dasgupta A; Dennen DA; Saldana S; Chou H; McLawhon RW
    Clin Chem; 1990 Jan; 36(1):171-2. PubMed ID: 2297924
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

  • 3. Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients.
    Avendaño C; Alvarez JS; Sacristan JA; Adin J; Alsar MJ
    Ther Drug Monit; 1991 Nov; 13(6):523-7. PubMed ID: 1771650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
    Karboski JA; Godley PJ; Frohna PA; Horton MW; Reitmeyer WJ
    Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay.
    Dasgupta A; Nakamura A; Doria L; Dennen D
    Clin Chem; 1989 Feb; 35(2):323-4. PubMed ID: 2914387
    [No Abstract]   [Full Text] [Related]  

  • 6. Endogenous digoxin-like substances.
    J Pediatr; 1986 Nov; 109(5):910-1. PubMed ID: 3772672
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin automated immunoassay.
    Lacarelle B; Durand A; Labadie N; Cano JP
    Ther Drug Monit; 1989 Nov; 11(6):725-7. PubMed ID: 2595757
    [No Abstract]   [Full Text] [Related]  

  • 8. Tentative identification of a digoxin-like immunoreactive substance.
    Toseland PA; Oldfield PR; Murphy GM; Lawson AM
    Ther Drug Monit; 1988; 10(2):168-71. PubMed ID: 3381233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inaccuracies in digoxin measurement.
    Cook JD; Koch TR; Cook MS; Knoblock EC
    Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assay.
    Kulaots IA; Pudek MR; Seccombe DW
    Clin Chem; 1987 Aug; 33(8):1490-1. PubMed ID: 3301074
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of renal impairment on a new time-resolved fluoroimmunoassay for serum digoxin.
    Paterson NC; Stewart MJ
    Ann Clin Biochem; 1987 Mar; 24 ( Pt 2)():205-6. PubMed ID: 3592569
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
    Loucari-Yiannakou E; Yiannakou L; Souvatzoglou A; Diamandis EP
    Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin--issues and controversies.
    Soldin SJ
    Clin Chem; 1986 Jan; 32(1 Pt 1):5-12. PubMed ID: 3510096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.
    Howarth DM; Sampson DC; Hawker FH; Young A
    Anaesth Intensive Care; 1990 Feb; 18(1):45-52. PubMed ID: 2159733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.
    Fitzsimmons WE
    Drug Intell Clin Pharm; 1986; 20(7-8):538-42. PubMed ID: 3755675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].
    Romano L; Zofra S; Imperato G; Adorno V; Maglione A
    Arch Monaldi; 1985; 40(3-4):157-64. PubMed ID: 3842060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.